Contract # HDTRA114C0115
    PSC AN12 R&d- Medical: Biomedical (Appl...
    Set-Aside None
    Status Partially Executed
    POP 6/10/14 - 2/9/19 (4 years)
  • $5m Dollars Obligated
  • $7.7m Base & Exercised Options
  • $7.7m Base & All Options (Ceiling)
  • Cost Plus Fixed Fee Pricing Type
  • Partially Funded Funding Status
  • Full and Open Competition, 8 offer(s) Extent Competed


Amount Date Reason For Modification
-- 10/30/17 Supplemental Agreement For Work Within Scope

DEVELOPMENT OF A BROAD-SPECTRUM MONOCLONAL COCKTAIL FOR PREVENTION OF VEEV, WEEV AND EEV.

-- 5/24/17 Supplemental Agreement For Work Within Scope

NO COST EXTENSION TO OP1

$1.1m 1/12/17 Funding Only Action

INCREMENTAL FUNDING

$1.1m 5/27/16 Exercise An Option

OPTION PERIOD I - PSC: AN12

-- 11/24/15 Supplemental Agreement For Work Within Scope

BASE PERIOD - PSC: AN12

-- 5/20/15 Supplemental Agreement For Work Within Scope

BASE PERIOD - PSC: AN12

$2.5m 6/10/14 Not Listed

BASE PERIOD - PSC: AN12 RESEARCH AND DEVELOPMENT SERVICES